Induction of Myocarditis and Valvulitis in Lewis Rats by Different Epitopes of Cardiac Myosin and Its Implications in Rheumatic Carditis
Open accessAbstract
Immune responses against cardiac myosin and group A streptococcal M protein have been implicated in the pathogenesis of rheumatic heart disease. Although cardiac myosin is known to produce myocarditis in susceptible animals, it has never been investigated for its role in production of valvular heart disease, the most serious sequelae of group A streptococcal infection in acute rheumatic fever. In our study, cardiac myosin induced valvulitis in the Lewis rat, and epitopes responsible for production of valvulitis were located in the rod region. Human and rat cardiac myosins induced severe myocarditis in the Lewis rats as expected. A purified S2 fragment (amino acid sequences 842 to 1295) produced the most severe myocarditis as well as valvulitis. Different regions of light meromyosin produced valvulitis (residues 1685 to 1936) or myocarditis (residues 1529 to 1611). Because streptococcal M proteins produced valvular heart disease in Lewis rats and have been linked to anti-cardiac myosin responses, we reacted myosin-sensitized lymphocytes isolated from the hearts of Lewis rats with peptides of streptococcal M5 protein in tritiated thymidine assays. Infiltrating lymphocytes responded most strongly to peptides within the B repeat region of streptococcal M protein. These data show direct evidence that immune responses against cardiac myosin lead to valvular heart disease and the infiltration of the heart by streptococcal M protein reactive T lymphocytes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Crossreactivity between T cells targeting bacterial pathogens and the β-MyHC isoform has been validated in rat models for rheumatic heart disease.
“This crossreactivity has been further validated in rat models for rheumatic heart disease, suggesting the potential interplay between T cells targeting bacterial pathogens and the β -MyHC isoform. 285,286”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [286]
Cited by
Sorted by citations
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237 · see citing works
Mimicry and Antibody-Mediated Cell Signaling in Autoimmune Myocarditis
Li, Y., Heuser, J. S., Cunningham, L. C., Kosanke, S. D., & Cunningham, M. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8234 · Cited by 155 · see citing works
Self-citationLi, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3225 · Cited by 73 · see citing works
Self-citationAutoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51 · see citing works
- Authors
- Galvin, J. E., Hemric, M. E., Kosanke, S. D., Factor, S. M., Quinn, A., & Cunningham, M. W.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Cunningham, Madeleine W.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 160
- Issue
- 1
- Pages
- 297-306
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1867128
- OpenAlex
- W2152865075
- Cited by
- 99
- References
- 0
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Oklahoma
- National Institutes of Health (HL56267)
- University of Oklahoma Health Sciences Center
- National Heart, Lung, and Blood Institute (R56HL056267, R01HL056267, R37HL035280, HL-56267, HL35280)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- cardiac myosin, myocarditis, valvulitis, rheumatic heart disease, rheumatic fever, epitope mapping, light meromyosin, T cell infiltration, Lewis rats, autoimmunity
- MeSH terms
- Animals, Epitopes, Antigens, Bacterial, Bacterial Outer Membrane Proteins, Carrier Proteins, Cell Division, Heart Valve Diseases, Humans, Inflammation, Lymphocytes, Myocarditis, Myocardium, Myosins, Peptide Fragments, Rats, Inbred Lew, Rheumatic Heart Disease, Myosin Subfragments, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review